MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1002/mdc3.12742

Медицинская библиотека · Movement disorders clinical practice · 2019

Comparison of the Huntington's Disease like 2 and Huntington's Disease Clinical Phenotypes.

Anderson David G, Ferreira-Correia Aline, Rodrigues Filipe B, Aziz N Ahmad, Carr Jonathan, Wild Edward J, Margolis Russell L, Krause Amanda

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Huntington's disease like 2 (HDL2) is the most common Huntington's disease (HD) phenocopy in many countries and described as the phenocopy with the greatest resemblance to HD. The current clinical description of HDL2 is based on retrospective data. It is unknown whether HDL2 has clinical features that distinguish it from HD.

OBJECTIVE

To describe the HDL2 phenotype and compare it to HD systematically.

METHODS

A blinded cross-sectional design was used to compare the HDL2 (n = 15) and HD (n = 13) phenotypes. African ancestry participants underwent assessments, including the Unified Huntington's Disease Rating Scale (UHDRS). The UHDRS motor component was video recorded and evaluated by blinded experts and the inter-rater reliability calculated.

RESULTS

Both groups were homogeneous in terms of demographics and disease characteristics. However, HDL2 patients presented three years earlier with more prominent dysarthria and dystonia. Raters could not distinguish between the two diseases with a high level of agreement. No significant differences in the TMS between HDL2 and HD were found. In both disorders, disease duration correlated with motor scores, with the exception of chorea. Psychiatric and cognitive scores were not significantly different between the groups.

CONCLUSIONS

The HDL2 phenotype is similar to HD and is initially characterized by dementia, chorea, and oculomotor abnormalities, progressing to a rigid and bradykinetic state, suggesting the UHDRS is useful to monitor disease progression in HDL2. Although HDL2 patients scored higher on some UHDRS domains, this did not differentiate between the two diseases; it may however be emerging evidence of HDL2 having a more severe clinical phenotype.

Для цитирования: Anderson David G, Ferreira-Correia Aline, Rodrigues Filipe B, Aziz N Ahmad, Carr Jonathan, Wild Edward J, Margolis Russell L, Krause Amanda. Comparison of the Huntington's Disease like 2 and Huntington's Disease Clinical Phenotypes.. Movement disorders clinical practice. 2019. DOI: 10.1002/mdc3.12742.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.